Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KAPA

Kairos Pharma Ltd

May 12 • 04:00PM ET

0.4850

-0.0450 -8.49 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: IMNN BLRX TNXP SABS PALI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	42.08%	Shs Outstand	20.82M	Perf Week	-12.61%
Market Cap	10.39M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.00%	Shs Float	12.40M	Perf Month	-17.09%
Enterprise Value	4.81M	PEG	-	EPS next Q	-0.07	Inst Own	4.76%	Short Float	1.01%	Perf Quarter	-24.34%
Income	-5.06M	P/S	-	EPS this Y	-26.67%	Inst Trans	11.78%	Short Ratio	0.25	Perf Half Y	-43.12%
Sales	0.00M	P/B	1.32	EPS next Y	-76.32%	ROA	-77.46%	Short Interest	0.13M	Perf YTD	-31.69%
Book/sh	0.37	P/C	1.86	EPS next 5Y	-	ROE	-92.07%	52W High	2.11 -77.01%	Perf Year	-24.22%
Cash/sh	0.26	P/FCF	-	EPS past 3/5Y	-4.30% -23.37%	ROIC	-66.05%	52W Low	0.40 21.25%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.58% 5.97%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-41.80%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	16.56	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	29.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	16.56	EPS Q/Q	15.09%	SMA20	-17.45%	Beta	1.49	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-18.67%	Rel Volume	0.54	Prev Close	0.53
Employees	-	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-44.73%	Avg Volume	506.83K	Price	0.49
IPO	Sep 16, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-274.33% -	Trades		Volume	274,888	Change	-8.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)